Rituxan With or Without Methotrexate in Psoriatic Arthritis

ClinicalTrials.gov ID: NCT00509678

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00509678. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase IB, Investigator-Initiated, Open-Label, Multi-Center Trial of Rituximab With or Without Methotrexate In Subjects With Psoriatic Arthritis and Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to help determine the effectiveness of rituxan (with or without methotrexate) in the treatment of psoriatic arthritis.

Study identification

NCT ID: NCT00509678
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Swedish Medical Center; Other
Enrollment: 6 participants

Conditions and interventions

Conditions

Psoriatic Arthritis

Interventions

Rituximab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2006 (Type not available)
Primary completion: Jan 2010 (Actual)
Completion: Mar 2010 (Actual)
Last update posted: Jan 18, 2012

2006 – 2010

United States locations

U.S. sites: 4
U.S. states: 3
U.S. cities: 4

Facility	City	State	ZIP	Site status
University of California, San Diego	La Jolla	California	92037-0943	—
Stanford University	Stanford	California	94305-5350	—
University of Rochester	Rochester	New York	14642	—
Swedish Rheumatology Research	Seattle	Washington	98104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00509678, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 18, 2012 · Synced Nov 13, 2026